Results 1 to 10 of about 9,593,465 (402)
Epidemiology, management and outcomes of Graves’ disease—real life data. [PDF]
Endocrine, 2017 PURPOSE: Treatment options in Graves' disease are clearly defined, but management practices and the perceptions of success are varied. The outcomes of treatment in large consecutive cohorts of Graves' disease have not been well characterised.
Allahabadia, A. +3 more
core +2 more sources
Thyroid function disorders [PDF]
Arhiv za farmaciju, 2022 Thyroid function disorders are the most common endocrine disorders in humans. They are frequently diagnosed, with prevalence varying between 2 and 6%, and a female to male ratio of up to 10:1.
Stojković Mirjana
doaj +1 more source
Journal of Education, Health and Sport, 2023 Background: Graves' disease is responsible for 60-80% causes of hyperthyreosis. An important role in the pathogenesis is played by anti-TSHR immunoglobulins (TRAb), that stimulate TSH receptors leading to excessive hormone synthesis and release by the ...
Natalia Woś +9 more
doaj +1 more source
Graves’ disease: moving forwards
Archives of Disease in Childhood, 2022 Graves’ disease is a rare disorder that continues to present clinicians and families with a series of challenges. There are no new established treatments for children or adolescents, but the outcomes of recent clinical trials and meta-analyses have ...
L. Lane, Claire L Wood, T. Cheetham
semanticscholar +1 more source
Two further cases of Graves’ disease following SARS-Cov-2 vaccination
Journal of Endocrinological Investigation, 2021 Recently, two cases of Graves’ disease after SARS-Cov2 RNA vaccination with tozinameran have been reported [1]. Here, we report two further cases: a late recurrence after 17 years and an initial manifestation. A 71-year-old lady had subtotal resection of
G. Zettinig, M. Krebs
semanticscholar +1 more source
Evans syndrome and Graves' Disease: An unusual presentation – A case report
Apollo Medicine, 2022 Introduction: Evans syndrome (ES), an infrequently encountered haematological condition, is characterized by coombs-positive autoimmune hemolytic anaemia (AIHA) in association with immune thrombocytopenia (ITP). The association of ES with Graves' disease
Amtoj Singh Lamba +3 more
doaj +1 more source
SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves’ disease
Endocrine, 2021 Coronavirus disease 2019 (COVID-19) advances to affect every part of the globe and remains a challenge to the human race. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) was shown to affect many organs and organ systems including the thyroid
A. K. Murugan, A. Alzahrani
semanticscholar +1 more source
Frontiers in Public Health, 2021 Background: Mounting evidence has revealed the interrelationship between thyroid and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to explain the thyroid dysfunction and autoimmune thyroid disorders observed after coronavirus disease 2019 (
D. Lui +5 more
semanticscholar +1 more source
The Role of the Microbiota in Graves’ Disease and Graves’ Orbitopathy
Frontiers in Cellular and Infection Microbiology, 2021 Graves‘ disease (GD) is a clinical syndrome with an enlarged and overactive thyroid gland, an accelerated heart rate, Graves’ orbitopathy (GO), and pretibial myxedema (PTM). GO is the most common extrathyroidal complication of GD. GD/GO has a significant
Jueyu Hou +3 more
semanticscholar +1 more source
Graves’ disease and Graves’ orbitopathy following COVID-19
Journal of Endocrinological Investigation, 2021 Upon genetic predisposition, Graves’ disease (GD) is believed to be triggered by nongenetic factors, including infections [1]. The immune system plays a role in Coronavirus disease 2019 (COVID-19), being involved in its clinical course and outcome [2 ...
G. Lanzolla, C. Marcocci, M. Marinò
semanticscholar +1 more source